After this operation, the rebels move towards the transplant in search of its destruction, but are eliminated by a molecule called FasL, a team from the American universities of Missouri, Harvard and the Georgia Institute of Technology explained in an article.
He cited the possibility of potentially lifelong abstinence from taking immunosuppressive drugs, which counteract the immune system’s ability to find and kill a foreign object once it enters the body, as an advantage.
“The main problem with immunosuppressive drugs is that they are not specific, so they can have many side effects, such as B. a high cancer development rate,” said one of the lead authors, Haval Shirwan.
So with our technology, we found a way to modulate, or train, the immune system to accept these transplanted cells and not reject them, he said.
Shirwan and Esma Yolcu, also a professor of child health and molecular microbiology and immunology at the Missouri School of Medicine, have spent the past two decades focusing on finding a mechanism to fight type 1 diabetes.
The disease affects about 1.8 million Americans, with life-threatening problems such as heart disease, kidney damage and vision loss, according to official estimates.
Although it develops in childhood or adolescence, it can appear in adulthood, there is no cure, and treatments include taking insulin, monitoring diet, controlling blood sugar levels, and regular exercise.
car/znc